The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.
about
Interpreting patient-reported outcomes from clinical trials in COPD: a discussionIs aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis.Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study.Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study.The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.
P2860
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The effect of aclidinium bromi ...... two 6-month Phase III studies.
@en
type
label
The effect of aclidinium bromi ...... two 6-month Phase III studies.
@en
prefLabel
The effect of aclidinium bromi ...... two 6-month Phase III studies.
@en
P2093
P2860
P1433
P1476
The effect of aclidinium bromi ...... two 6-month Phase III studies.
@en
P2093
Asha Hareendran
Esther Garcia Gil
Ferran Chuecos
Nancy K Leidy
Paul W Jones
Rosa Lamarca
P2860
P2888
P356
10.1186/S12931-016-0372-1
P577
2016-05-23T00:00:00Z
P6179
1009868593